Regenics vs bmiMD: semaglutide vs tirzepatide pricing and access
Quick verdict: Regenics and bmiMD both offer compounded GLP-1 options by telehealth, but Regenics highlights compounded semaglutide plus tirzepatide with nurse-practitioner-led care and promotional first-month pricing, while bmiMD centers on compounded tirzepatide with multi-month pricing tiers and 24/7 clinician access. This makes Regenics a cash-pay entry for semaglutide or tirzepatide, and bmiMD an option for lower long-term monthly cost if you commit to multi-month plans.
Explore Regenics semaglutide from $139
Key difference 1: Medications offered and focal therapies
Regenics offers both compounded semaglutide and compounded tirzepatide plus an optional Sermorelin peptide line. bmiMD documentation focuses on compounded tirzepatide only. If access to semaglutide or an add-on peptide matters to you, Regenics explicitly lists semaglutide and Sermorelin; bmiMD emphasizes tirzepatide.
Key difference 2: Pricing structure and promotions
Both providers publish starting rates, but structures differ. Regenics shows promotional first-month pricing: semaglutide $139 first month (renews $199/month) and tirzepatide $189 first month (renews $279). bmiMD posts tirzepatide month-to-month at $179, with lower monthly equivalents for 3, 6, and 12 month plans down to $139/month for a 12-month plan. Promotional pricing at Regenics applies to the first month only; bmiMD requires a multi-month commitment to reach the lowest monthly equivalent.
Compare Regenics pricing details
Key difference 3: Clinical oversight and access
Regenics describes nurse-practitioner-led GLP-1 care where licensed nurse practitioners review intake before anything is prescribed. bmiMD highlights clinician-reviewed online treatment and advertises 24/7 clinician access. Both state treatment is available only when a licensed clinician determines it is medically appropriate.
Key difference 4: Pharmacy practices, verification, and regulatory notes
Both providers use compounded medications prepared by U.S. pharmacies. Regenics notes its pharmacy network is LegitScript certified and that compounded medications are not FDA-approved finished products and are not reviewed by FDA for safety, effectiveness or quality. bmiMD states medications are prepared in state-licensed pharmacies and confirms compounded medications are not FDA-approved and not reviewed by FDA for safety, effectiveness or quality. Each provider preserves the regulatory qualifier about compounded products.
Comparison table: Regenics vs bmiMD at a glance
| Criteria | Regenics | bmiMD |
|---|---|---|
| Primary medications offered | Compounded semaglutide and tirzepatide; Sermorelin peptide add-on | Compounded tirzepatide |
| Starting price | Semaglutide $139 first month; tirzepatide $189 first month | Tirzepatide $179 month-to-month; $159 3-mo; $149 6-mo; $139 12-mo |
| Renewal / commitment | Promotional first month then higher renewal pricing (eg semaglutide renews $199) | Lowest monthly equivalent requires multi-month plan; monthly or subscription options available |
| Clinical access | Licensed nurse practitioners review intake before prescriptions | Clinician-reviewed online care with 24/7 clinician access |
| Pharmacy verification | U.S. compounding pharmacies; LegitScript certified network | State-licensed pharmacies; lab verification claims |
| Regulatory note | Compounded medications are not FDA-approved as finished products | Compounded medications are not FDA-approved as finished products |
Other practical differences and obligations
Regenics emphasizes no insurance required and that plans are FSA/HSA eligible. bmiMD notes free subscription shipping and a stated refundability if not eligible for the program; bmiMD also stresses confirming total prepaid charge and state availability. Both flag that treatment is subject to clinician review and that compounded medications are not FDA-approved.
Check bmiMD subscription options
Final thoughts on Regenics vs bmiMD
Regenics vs bmiMD boils down to medication variety and pricing model. Regenics is positioned for people wanting a cash-pay entry to semaglutide or tirzepatide with nurse-practitioner-led telehealth and an optional peptide line, using a promotional first-month price that renews higher. bmiMD centers on compounded tirzepatide with tiered multi-month pricing and around-the-clock clinician access, with the lowest monthly price requiring a longer commitment. Both use compounded medications and include the same regulatory qualifier about FDA review.
Start Regenics telehealth enrollment
Choose Regenics if…
you want access to both compounded semaglutide and tirzepatide, a Sermorelin peptide option, nurse-practitioner-led telehealth, and promotional first-month semaglutide pricing starting at $139, understanding renewals are higher and that compounded medications are not FDA-approved.
Choose bmiMD if…
you plan to use compounded tirzepatide and prefer lower long-term monthly equivalents through a 3, 6, or 12 month plan, value 24/7 clinician access and free subscription shipping, and will confirm total prepaid charges and state availability before enrolling.
Primary keyword: Regenics vs bmiMD